Fate Therapeutics

In News

487,728 Shares in Fate Therapeutics, Inc. $FATE Acquired by Ieq Capital LLC - MarketBeat

MarketBeat - Aug 27, 2026

Fate Therapeutics begins Phase II trial of FT819 for lupus nephritis - Clinical Trials Arena

Clinical Trials Arena - Aug 17, 2026

Fate Therapeutics Gets FDA Clearance for FT839 Autoimmune CAR-T Therapy - The Clinical Trial Vanguard

The Clinical Trial Vanguard - Jul 10, 2026

Fate Therapeutics (FATE) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Yahoo Finance - Aug 13, 2026

Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis - GlobeNewswire

GlobeNewswire - Aug 14, 2026

FATE Stock Price and Chart — NASDAQ:FATE - TradingView

TradingView - Aug 09, 2026

Fate Therapeutics Initiates Potentially Registrational Trial of Off-the-Shelf CAR T-Cell Therapy FT819 for Lupus Nephritis - BioPharm International

BioPharm International - Aug 14, 2026

Fate’s off-the-shelf CAR-T therapy shows early promise in treatment-resistant autoimmune disease - Fierce Biotech

Fierce Biotech - Jul 09, 2026

FT819 Remodels Lupus B Cells in Clinical Trial - CRISPR Medicine News

CRISPR Medicine News - May 13, 2026

Fate Therapeutics: Q2 Earnings Snapshot - KVUE

KVUE - Aug 13, 2026

Fate Therapeutics (FATE) Short Interest & Short Float | Updated Aug 2026 $FATE - MarketBeat

MarketBeat - Aug 25, 2026

Fate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates - Yahoo Finance

Yahoo Finance - Aug 13, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment